论文部分内容阅读
1993年,世界卫生组织正式将血管紧张素转换酶抑制剂(ACEI)——“普利家族”列为一线降压药物,从而为抗高血压治疗增添了一个具有里程碑意义的药物,卡托普利则是这个庞大的“普利家族”里效果不错且价格又便宜的短效药。许多高血压患者也因此把它们看作是治疗的福音,真的是这样吗?现在,就让我们和专家一起走近“普利家族”,去看看它们都有哪些作用。
In 1993, WHO formally listed the ACE inhibitor (“ACE inhibitor”) “Puli family” as a front-line antihypertensive drug, adding a landmark drug to antihypertensive therapy. Benefit is the short-acting drug that works well and is cheap at this massive “Puli family.” So are so many hypertensive patients seeing them as a cure for the gospel? Is that really true? Now, let’s get together with experts to visit the Puli Family to see what they all do.